Discover six MASH companies to keep an eye on as the race to shape the next generation of liver disease therapies heats up.
Tangram Therapeutics (Tangram), a company committed to unlocking transformative RNAi medicines for meaningful patient impact, ...
LONDON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- (“Tangram”), a company committed to unlocking transformative RNAi medicines for meaningful patient impact, today announced progression of its MASH ...
Last patient completed final 72-week visit in NATiV3, with 1,009 patients enrolled in the main cohort and 410 patients in the ...
University of Utah Health researchers have shown that a protein involved in cancer growth also plays a role in whether a ...
Longer treatment with an Akero Therapeutics drug in development for the liver disease MASH led to better results, including improvement in fibrosis, the liver scarring that is a hallmark of the ...
Fox will celebrate MASH: The Comedy That Changed Television in a new two-hour special set to air Monday, January 1 at 8 pm on the network. A definitive look at the 14-time Emmy-winning television ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results